Skip to main content

I couldn’t have said it better myself, Sophia! A major take-away I got from Dr. Gerszten’s presentation was that yes, there is huge potential for ground-breaking discoveries within these transient molecules, but how realistic is it to actually pinpoint exactly which ones are pathologically important in addition to variability in testing populations? It may be a little naïve for me to say that our post-discussion gave me a rather chilling awakening regarding the complexity of diseases, but as an old colleague of mine used to say, “If it isn’t hard, someone would’ve done it already!”

It was a pleasure to hear Dr. Gerszten speak and well written Austin!

Thalia Hua

Plain text

  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.